Company Filing History:
2 out of 164 
2 out of 38 
Years Active: 2012-2013
Title: Innovations of John Patrick Herich
Introduction
John Patrick Herich is a notable inventor based in Cardiff, California. He has made significant contributions to the field of biotechnology, particularly in the development of bioassays for measuring GLP-1 receptor agonist activity. With a total of two patents to his name, Herich's work has implications for diabetes treatment and research.
Latest Patents
Herich's latest patents focus on GLP-1 receptor agonist bioassays. These patents provide cell-based bioassays for measuring the activity of test compounds, including GLP-1 receptor agonist compounds such as exendins and their analogs. The bioassays are designed to quantitatively determine cAMP generated in samples containing these compounds, which can be correlated to their agonist activity. Suitable methods for these bioassays include enzyme-linked immunosorbent assays and homogeneous time-resolved fluorescence assays.
Career Highlights
Throughout his career, John Patrick Herich has worked with prominent companies in the pharmaceutical industry. He has been associated with Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of biotechnology.
Collaborations
Herich has collaborated with notable professionals in his field, including Michalis Nicolaou and Frederick Charles Bancroft. These collaborations have likely enhanced his research and development